Cancer
Liaison Program
Cancer Related Articles
2006
- The Importance of Patient-Reported
Outcomes ... It's All About the Patients. FDA Consumer, November-December
How patients feel and function
has taken on new importance in clinical trials and in making claims about
drugs and medical devices.
- New Health Initiative to Improve Cancer Treatments, FDA
Consumer, May-June
- From Test Tube To Patient: Protecting
America's Health Through Human Drugs, 4th edition, January
2005
- Take Time for a Mammogram, FDA Consumer, September-October
- Teen Tanning Hazards, FDA Consumer, March-April
2004
2003
- Statement of Theresa M. Mullin, Ph.D., Assistant Commissioner for Planning, FDA, Before the Subcommittee on Health
Committee on Energy and Commerce, House of Representatives Hearing about collaborative
efforts with the National Cancer Institute to facilitate cancer drug development,
July 10
- Joint FDA, NCI Program Aims
to Streamline Cancer Drug Development, FDA Consumer, July-August
- Turning Up the Heat on Acrylamide, Linda Bren, FDA Consumer, January-February
2002
- FDA Public Meeting on Acrylamide
in the U.S. Food Supply, Remarks by Lester M. Crawford, Jr., D.V.M., Ph.D.,
FDA Deputy Commissioner, September 30
- The FDA's Drug Review Process:
Ensuring Drugs are Safe and Effective, FDA Consumer, July-August
- Bringing Real Life to the Table:
Patient Reps Help FDA Review Products, FDA Consumer, January-February
2002
- FDA Approves Gleevec for Leukemia
Treatment, FDA Consumer, July-August
- Grappling With the Quality of
Life: Patients, FDA and Drug Companies Struggle to Link Therapies With Well-Being, Carol Lewis, FDA Consumer, March-April
- Testimony of Robert J. Temple,
M.D., Associate Director for Medical Policy, Center for Drug
Evaluation and Research and Patty Delaney, Cancer Liaison Program, Office
of Special Health Issues, to discuss an important issue of the availability
of investigational drugs for what is commonly referred to as compassionate
use before the Committee on Government Reform, U.S. House of Representatives,
June 20
2000
1999
1998
1997
- Understanding Clinical Trials From the Patient's Perspective,
by Patty Delaney, May/June
- The FDA, What Does It Do For Cancer Patients?,
by Patty Delaney, September/October
- Waging War on Lung Cancer,
by Ellen Brown, FDA Consumer May-June
- The Value of Patient's Perspective in FDA Decision
Processes, Sharon Smith Holston, Deputy Commissioner for External Affairs,
November 3, 1997
- Giving Thalidomide a Second
Chance, by Herbert Burkholz, FDA Consumer, September-October
- Thalidomide, Important Patient Information Center for Drug Evaluation and Research, FDA
- Thalidomide: Potential Benefits and Risks,
Executive Summary of an Open Public Scientific Workshop, National Institutes
of Health, September 9-10
1995
- Thwarting Skin Cancer with Sun
Sense by Carolyn J. Strange, FDA Consumer, July/August
Cancer Liaison Program
Home Page